Kymera TherapeuticsKYMR
13F holders, Q1 2025 (March 31)At the end of Q1 2025, 173 institutions reported holding Kymera Therapeutics Inc. (KYMR) in their 13F filings, down 7 from Q4 2024. 22 opened new positions and 29 sold out. The largest holders were T. Rowe Price Associates Inc. ($183.4M), Avoro Capital Advisors LLC ($176.8M) and Wellington Management Group LLP ($164.1M). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Kymera Therapeutics Inc.
- CUSIP
- 501575104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 22 | $18.7M |
| Exits | 29 | $76.0M |
All 13F filers, Q4 2024 → Q1 2025: 5,505,758 shares bought and 4,369,286 shares sold, net +1,136,472 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 173 holders
| T. Rowe Price Associates Inc. | 0.02% | Reduce -2.4% | 6,702,450 | $183.4M |
| Avoro Capital Advisors LLC | 2.76% | Add +25.4% | 6,460,000 | $176.8M |
| Wellington Management Group LLP | 0.03% | Add +13.0% | 5,996,873 | $164.1M |
| Baker Bros. Advisors LP | 1.84% | No change | 5,995,929 | $164.1M |
| Vanguard Group Inc. | 0.00% | Add +7.0% | 5,231,392 | $143.2M |
| BVF Inc. | 5.76% | No change | 5,161,801 | $141.3M |
| Atlas Venture Life Science Advisors, LLC | 25.69% | No change | 4,896,462 | $134.0M |
| FMR LLC | 0.01% | Reduce -8.7% | 4,409,234 | $120.7M |
| BlackRock, Inc. | 0.00% | Reduce -1.7% | 4,282,903 | $117.2M |
| Siren, L.L.C. | 5.00% | Add +9.1% | 3,240,313 | $88.7M |
| State Street Corp. | 0.00% | Add +4.3% | 1,760,707 | $48.2M |
| Driehaus Capital Management LLC | 0.31% | Reduce -15.9% | 1,168,791 | $32.0M |
| Geode Capital Management, LLC | 0.00% | Add +2.6% | 1,133,765 | $31.0M |
| Redmile Group, LLC | 2.54% | Reduce -10.6% | 983,413 | $26.9M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.01% | Add +121.5% | 896,404 | $24.5M |
| Janus Henderson Group PLC | 0.01% | Add +104.2% | 770,582 | $22.8M |
| Rock Springs Capital Management LP | 1.25% | Reduce -23.2% | 794,437 | $21.7M |
| Merck & Co., Inc. | 12.86% | No change | 772,165 | $21.1M |
| UBS Group AG | 0.00% | Add +26.3% | 593,606 | $16.2M |
| Deerfield Management Company, L.P. | 0.37% | No change | 593,000 | $16.2M |
| Jennison Associates LLC | 0.01% | Reduce -23.0% | 552,286 | $15.1M |
| Woodline Partners LP | 0.09% | Reduce -2.3% | 525,245 | $14.4M |
| Eventide Asset Management, LLC | 0.29% | Add +15.2% | 525,138 | $14.4M |
| Millennium Management | 0.01% | Add +340.4% | 510,480 | $14.0M |
| AJU IB Investment Co., Ltd. | 14.88% | No change | 457,059 | $12.5M |
| Northern Trust Corp. | 0.00% | Reduce -3.7% | 421,660 | $11.5M |
| Massachusetts Financial Services Co. | 0.00% | Add +0.1% | 420,045 | $11.5M |
| Deer Management Co. LLC | 1.05% | No change | 415,895 | $11.4M |
| Dimensional Fund Advisors LP | 0.00% | Reduce -8.8% | 395,468 | $10.8M |
| Charles Schwab Investment Management Inc. | 0.00% | Reduce -1.4% | 381,708 | $10.4M |
| Capital Research Global Investors | 0.00% | New | 365,190 | $10.0M |
| Goldman Sachs Group Inc. | 0.00% | Reduce -20.7% | 344,237 | $9.4M |
| Boxer Capital Management, LLC | 2.68% | Reduce -23.5% | 325,000 | $8.9M |
| Gilder Gagnon Howe & Co. LLC | 0.11% | Reduce -2.4% | 318,381 | $8.7M |
| TD Asset Management Inc | 0.01% | Reduce -11.6% | 202,092 | $5.5M |
| Marshall Wace, LLP | 0.01% | Add +2853.9% | 201,900 | $5.5M |
| Two Sigma Advisers, LP | 0.01% | Reduce -29.6% | 183,300 | $5.0M |
| Morgan Stanley | 0.00% | Reduce -28.2% | 172,082 | $4.7M |
| Schroder Investment Management Group | 0.00% | Reduce -3.4% | 158,338 | $4.7M |
| Two Sigma Investments, LP | 0.01% | Reduce -15.0% | 147,620 | $4.0M |
| Foresite Capital Management VI LLC | 2.19% | No change | 146,332 | $4.0M |
| Voloridge Investment Management, LLC | 0.01% | Reduce -2.0% | 144,224 | $3.9M |
| Nuveen, LLC | 0.00% | — | 143,238 | $3.9M |
| Manufacturers Life Insurance Company, The | 0.00% | Reduce -3.2% | 142,587 | $3.9M |
| Patient Square Capital LP | 1.61% | New | 142,201 | $3.9M |
| Aquilo Capital Management, LLC | 10.22% | Reduce -24.5% | 138,521 | $3.8M |
| Checkpoint Capital L.P. | 2.05% | Add +76.2% | 136,605 | $3.7M |
| Frontier Capital Management Co. LLC | 0.04% | Reduce -12.1% | 131,963 | $3.6M |
| Bank of New York Mellon Corp | 0.00% | Reduce -0.2% | 126,877 | $3.5M |
| Yiheng Capital Management, L.P. | 1.18% | New | 122,605 | $3.4M |
| AXA S.A. | 0.01% | Reduce -0.1% | 108,994 | $3.0M |
| Affinity Asset Advisors, LLC | 0.45% | Add +150.0% | 100,000 | $2.7M |
| Bank of America Corp. | 0.00% | Add +55.5% | 96,805 | $2.6M |
| Prudential Financial Inc. | 0.00% | Reduce -1.4% | 95,430 | $2.6M |
| First Trust Advisors LP | 0.00% | Reduce -46.8% | 93,795 | $2.6M |
| Barclays PLC | 0.00% | Reduce -15.6% | 85,212 | $2.3M |
| Universal- Beteiligungs- und Servicegesellschaft mbH | 0.00% | Reduce -25.8% | 85,046 | $2.3M |
| Russell Investments Group, Ltd. | 0.00% | Add +40.0% | 82,507 | $2.3M |
| Citigroup Inc. | 0.00% | Add +25.9% | 81,072 | $2.2M |
| Swiss National Bank | 0.00% | Reduce -1.2% | 75,300 | $2.1M |
| E Fund Management Co., Ltd. | 0.09% | Add +7.2% | 71,863 | $2.0M |
| Rhumbline Advisers | 0.00% | Add +9.0% | 69,928 | $1.9M |
| Jane Street Group, LLC | 0.00% | Add +290.1% | 65,399 | $1.8M |
| Susquehanna International Group, LLP | 0.00% | Add +109.7% | 63,768 | $1.7M |
| Rafferty Asset Management, LLC | 0.01% | Add +3.7% | 58,982 | $1.6M |
| State of Wisconsin Investment Board | 0.00% | Add +25.5% | 57,220 | $1.6M |
| Dark Forest Capital Management LP | 0.07% | Add +428.4% | 54,154 | $1.5M |
| Deutsche Bank AG | 0.00% | Reduce -25.4% | 54,007 | $1.5M |
| Norges Bank | 0.00% | Reduce -45.5% | 49,697 | $1.4M |
| Squarepoint Ops LLC | 0.00% | Add +1.7% | 49,189 | $1.3M |
| Schonfeld Strategic Advisors LLC | 0.01% | Reduce -77.7% | 48,160 | $1.3M |
| JPMorgan Chase & Co. | 0.00% | Add +26.5% | 46,874 | $1.3M |
| Alliancebernstein L.P. | 0.00% | Reduce -49.0% | 44,990 | $1.2M |
| Invesco Ltd. | 0.00% | Add +36.9% | 42,075 | $1.2M |
| Legal & General Group Plc | 0.00% | Reduce -0.0% | 40,037 | $1.1M |
| Voya Investment Management LLC | 0.00% | Reduce -36.8% | 38,624 | $1.1M |
| Skandinaviska Enskilda Banken AB (publ) | 0.01% | No change | 38,141 | $1.0M |
| California State Teachers Retirement System | 0.00% | No change | 36,839 | $1.0M |
| DekaBank Deutsche Girozentrale | 0.00% | No change | 23,562 | $951K |
| Franklin Resources Inc. | 0.00% | Reduce -14.4% | 32,827 | $898K |
| Intech Investment Management LLC | 0.01% | Add +50.6% | 32,792 | $898K |
| Gsa Capital Partners LLP | 0.08% | Add +6.8% | 31,537 | $863K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | Add +6.3% | 30,793 | $849K |
| Nan Fung Group Holdings Ltd | 0.69% | No change | 30,875 | $845K |
| Harbor Capital Advisors, Inc. | 0.04% | Reduce -24.7% | 30,878 | $845K |
| Verition Fund Management LLC | 0.00% | Add +459.0% | 29,890 | $818K |
| ExodusPoint Capital Management, LP | 0.01% | Add +108.8% | 29,501 | $807K |
| Erste Asset Management GmbH | 0.01% | No change | 27,000 | $800K |
| MetLife Investment Management, LLC | 0.00% | Reduce -1.5% | 27,787 | $761K |
| Cinctive Capital Management LP | 0.05% | Reduce -34.8% | 23,492 | $643K |
| Corebridge Financial, Inc. | 0.00% | Reduce -1.5% | 23,002 | $630K |
| Wells Fargo & Company | 0.00% | Add +2.3% | 22,433 | $614K |
| Comerica Bank | 0.00% | Add +3.6% | 21,374 | $585K |
| HSBC Holdings PLC | 0.00% | Add +6.1% | 18,547 | $508K |
| Teachers Retirement System of the State of Kentucky | 0.00% | No change | 17,907 | $490K |
| Handelsbanken Fonder AB | 0.00% | No change | 16,500 | $452K |
| Ameriprise Financial Inc. | 0.00% | Add +79.9% | 15,374 | $421K |
| New York State Common Retirement Fund | 0.00% | No change | 14,549 | $398K |
| Neo Ivy Capital Management | 0.13% | New | 14,420 | $395K |
| Natixis Advisors, LLC | 0.00% | Add +1.9% | 14,334 | $392K |
"% of holder's portfolio" is KYMR's weight in each manager's 13F, not the share of Kymera Therapeutics Inc. the manager owns.